The Section of Endocrinology and Investigative Medicine is funded by grants from the MRC, BBSRC, NIHR, an Integrative Mammalian Biology (IMB) Capacity Building Award, an FP7-HEALTH-2009-241592 EuroCHIP grant and is supported by the NIHR Biomedical Research Centre Funding Scheme
some studies show that the GLP-1 drug may even be effective at treating addiction, improving liver disease and improving sleep
Its lightweight texture absorbs quickly, leaving skin hydrated and protected without greasiness
1,5 The effective integration of GLP-1RAs into the arsenal of antidiabetic treatments along with their recent inclusion in clinical practice guidelines both for primary prevention of cardiovascular disease and secondary stroke prevention, 6,7 has accelerated the pace for the development of newer, enforced molecules that act as dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonists
[Crossref] [PubMed] Kim YS, Kim EY, Ahn HK, et al
.png)
